Treatment of Thrombotic Thrombocytopenic Purpura in Hereditary/Congenital TTP Remission (Non-Pregnant)

This protocol addresses the management of thrombotic thrombocytopenic purpura in patients with the hereditary or congenital form (cTTP) who are currently in remission and are not pregnant — a specific clinical situation requiring a tailored evidence-based approach.

Clinical Scenario

The patient has hereditary or congenital thrombotic thrombocytopenic purpura (cTTP), is currently in remission, and is not pregnant. This subpopulation is distinguished from acquired TTP and from pregnant patients with cTTP, and management recommendations differ accordingly.

Treatment Approach (Overview)

For patients with cTTP in remission, the evidence-based approach involves either a plasma-based intervention or an observational strategy — the choice between these paths depends on individual clinical factors. The full protocol specifies the criteria, sequencing, and practical considerations for each option.

Dosing details, full eligibility criteria, and the complete decision algorithm are available in the structured protocol below.

Instant Access to Structured Evidence-Based Regimens

References

DOI: 10.1111/jth.15010

For patients with cTTP who are in remission, the panel suggests either plasma infusion or a watch and wait strategy.
Regular plasma infusions involve the use of substantial infrastructure resources and a large volume of plasma, and impose a burden on patients who must travel to a hospital or an infusion center to receive such a treatment.

View source ↗